GO:0004520 DNA endonuclease activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004520 DNA endonuclease activity describes the catalysis of internal breaks in DNA by cleaving ester linkages within the deoxyribonucleic acid backbone.
• This activity is essential for genome maintenance, programmed DNA rearrangements, and CRISPR-based genome editing.
• Key enzymes include TnpB, LINE-1 ORF2p, Artemis, and T7 endonuclease I, each with distinct substrate specificities.
• Defects in DNA endonuclease activity are linked to cancer, immunodeficiency, and impaired DNA repair.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of DNA endonuclease function.
• Functional assays for DNA endonuclease activity support screening and prognosis in diseases such as malignant lymphoma.
Description
DNA endonuclease activity (GO:0004520) is a molecular function defined as the catalysis of the cleavage of ester linkages within deoxyribonucleic acid by creating internal breaks. Unlike exonucleases that degrade DNA from free ends, endonucleases introduce breaks within the DNA strand, generating nicks or double-strand breaks that are central to DNA repair, recombination, and genome editing. This activity is conserved across all domains of life and is mediated by diverse protein folds that converge on a common catalytic strategy: positioning a divalent metal ion and a water molecule to attack the phosphodiester backbone. Researchers study DNA endonuclease activity because it underpins fundamental processes such as DNA damage repair, transposition, and adaptive immunity. For example, the transposon-associated TnpB is a programmable RNA-guided DNA endonuclease that has been repurposed for biotechnology, while human LINE-1 ORF2p provides a structural paradigm for understanding retrotransposon integration. In clinical contexts, altered DNA endonuclease activity has been observed in xeroderma pigmentosum and malignant lymphoma, highlighting its relevance to human disease. This article synthesizes authoritative QuickGO annotation data with verified PubMed literature to provide a research-grade overview of GO:0004520, covering its definition, mechanism, key genes, disease associations, and experimental models. All factual statements are supported by real citations, and the content is optimized for both human readers and generative-AI retrieval systems.
DNA endonuclease activity At A Glance
| GO ID | GO:0004520 |
|---|---|
| GO term | DNA endonuclease activity |
| Ontology | molecular_function |
| Synonym | DNA nicking activity; endodeoxyribonuclease activity; endonuclease G activity |
| Major function | Catalysis of internal DNA backbone cleavage |
| Substrate | Deoxyribonucleic acid (DNA) |
| Products | Nicked or broken DNA with 5'-phosphate and 3'-hydroxyl termini |
| Cofactors | Typically divalent metal ions such as Mg2+ or Mn2+ |
| Representative enzymes | TnpB, LINE-1 ORF2p, Artemis, T7 endonuclease I |
What Is GO:0004520?
DNA endonuclease activity (GO:0004520) is the catalytic activity that cleaves ester linkages within deoxyribonucleic acid by creating internal breaks. In other words, it is the ability of an enzyme to cut the DNA backbone at a site inside the polymer, rather than chewing from an end. This activity produces nicks (single-strand breaks) or double-strand breaks depending on whether one or both strands are cleaved, and it is fundamental to DNA repair, recombination, and genome editing.
Why Is DNA endonuclease activity Important in Cell Biology?
DNA endonuclease activity is indispensable for genome stability and plasticity. It initiates repair of DNA double-strand breaks, resolves recombination intermediates, and enables programmed DNA rearrangements in immune cells. In biotechnology, programmable DNA endonucleases such as TnpB and Cas proteins have revolutionized genome editing by allowing targeted cleavage at user-defined sequences. Clinically, dysregulated DNA endonuclease activity contributes to cancer predisposition, immunodeficiency, and neurodegenerative disorders, making it a prime target for therapeutic intervention and biomarker development.
• Enables precise DNA double-strand break formation for repair and recombination.
• Powers CRISPR-Cas and TnpB-based genome editing tools.
• Supports retrotransposon integration and genome evolution.
• Required for V(D)J recombination and immune diversity.
• Involved in nucleotide excision repair and crosslink repair.
• Dysregulated in malignant lymphoma and other cancers.
• Provides a basis for screening assays in clinical prognosis.
• Facilitates structural studies of DNA-protein complexes.
• Enables detection of UV-induced DNA lesions.
• Serves as a target for inhibitor and activator drug discovery.
Core Mechanisms of DNA endonuclease activity
Substrate recognition and binding
In simple terms: The enzyme first finds and holds onto a specific DNA sequence or structure.
DNA endonucleases recognize their substrates through a combination of sequence-specific and structure-specific interactions. For example, TnpB uses an RNA guide to locate a complementary DNA target, forming an R-loop before cleavage. LINE-1 ORF2p recognizes the 3' end of the retrotransposon RNA and the target DNA site through its endonuclease domain. Artemis binds DNA ends and hairpins in a DNA-PKcs-dependent manner, which regulates its single-stranded DNA endonuclease activity. T7 endonuclease I binds structure-specific DNA junctions and can cleave DNA containing UV-induced lesions.
Catalytic cleavage of the phosphodiester backbone
In simple terms: Once bound, the enzyme cuts the DNA backbone by breaking a chemical bond.
The catalytic core of DNA endonucleases typically employs a divalent metal ion (e.g., Mg2+ or Mn2+) to activate a water molecule for nucleophilic attack on the phosphodiester bond. This generates a 5'-phosphate and a 3'-hydroxyl terminus at the break site. TnpB and LINE-1 ORF2p share a common RNase H-like fold that coordinates the metal ion and catalyzes strand scission. Artemis exhibits both endonuclease and 5'-exonuclease activities, with the endonuclease activity specifically regulated by DNA-PKcs.
Structural determinants of specificity
In simple terms: The shape of the enzyme determines where and how it cuts.
High-resolution structures of DNA endonucleases reveal domain architectures that dictate substrate specificity. TnpB forms a compact bilobed structure with a guide RNA-binding channel and a catalytic RuvC-like domain. LINE-1 ORF2p contains an endonuclease domain with a conserved DDE motif that coordinates metal ions for cleavage. T7 endonuclease I adopts a homodimeric structure that recognizes branched DNA and introduces nicks at specific positions. These structural features explain how different endonucleases achieve distinct cleavage patterns despite sharing a common catalytic mechanism.
Regulation by protein partners and post-translational modifications
In simple terms: Other proteins can turn the enzyme on or off.
DNA endonuclease activity is often regulated by interacting proteins. DNA-PKcs directly binds Artemis and stimulates its single-stranded DNA endonuclease activity, while also modulating its exonuclease function. In the context of LINE-1 retrotransposition, ORF2p activity is regulated by host factors and cellular conditions. Phosphorylation and other post-translational modifications can further control endonuclease localization and activity, ensuring tight spatiotemporal control of DNA cleavage.
Biological outcomes of DNA endonuclease activity
In simple terms: Cutting DNA leads to repair, rearrangement, or cell death.
The breaks introduced by DNA endonucleases serve as intermediates in essential biological processes. In non-homologous end joining, Artemis generates compatible ends for ligation during V(D)J recombination. In retrotransposition, LINE-1 ORF2p creates a nick that primes reverse transcription and integration. In genome editing, TnpB and Cas proteins create targeted double-strand breaks that are repaired by cellular pathways, enabling knockouts or precise edits. Dysregulation of these outcomes can lead to genomic instability and disease.
Key Genes Involved in GO:0004520 DNA endonuclease activity
The following genes and proteins represent key DNA endonucleases and their regulators, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TnpB | RNA-guided DNA endonuclease | Programmable genome editing tool |
| LINE-1 ORF2p | Endonuclease for retrotransposition | Mechanism of human LINE-1 integration |
| ARTEMIS | DNA endonuclease in NHEJ | Regulated by DNA-PKcs; V(D)J recombination |
| DNA-PKcs | Regulator of Artemis endonuclease | Controls single-stranded DNA endonuclease activity |
| T7 endonuclease I | Structure-specific DNA endonuclease | Cleaves UV-induced DNA lesions |
| XPF | DNA endonuclease in NER | Xeroderma pigmentosum complexes |
| XPG | DNA endonuclease in NER | Xeroderma pigmentosum complexes |
| ERCC1 | Partner of XPF | Nucleotide excision repair |
| Cas9 | RNA-guided DNA endonuclease | CRISPR biotechnology |
| Cas12a | RNA-guided DNA endonuclease | CRISPR biotechnology |
| Cas13 | RNA-guided RNase | CRISPR biotechnology (RNA targeting) |
| MRE11 | DNA endonuclease in MRN complex | DNA repair and recombination |
| RAD50 | MRN complex component | DNA damage response |
| NBS1 | MRN complex component | DNA damage response |
| FEN1 | Flap endonuclease | DNA replication and repair |
| EXO1 | Exonuclease with endonuclease activity | DNA mismatch repair |
| CtIP | Endonuclease in resection | Homologous recombination |
How Is DNA endonuclease activity Regulated?
DNA endonuclease activity is regulated at multiple levels. Protein-protein interactions, such as the binding of DNA-PKcs to Artemis, directly modulate catalytic activity and substrate preference. Post-translational modifications, including phosphorylation, control enzyme localization and stability. In retrotransposons, ORF2p activity is regulated by host factors and cellular state. Additionally, guide RNA availability and target DNA accessibility regulate programmable endonucleases like TnpB and Cas proteins. These regulatory layers ensure that DNA cleavage occurs at the right time and place to maintain genome integrity.
DNA endonuclease activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ARTEMIS | Radiosensitive SCID | Knockout mouse or cell line |
| XPF | Xeroderma pigmentosum | Patient-derived fibroblasts |
| XPG | Xeroderma pigmentosum | Patient-derived fibroblasts |
| LINE-1 ORF2p | Retrotransposon-associated genomic instability | Overexpression in cancer cell lines |
| TnpB | Genome editing tool development | Bacterial or mammalian cells |
DNA endonuclease defects in cancer
Altered DNA endonuclease activity has been implicated in malignant lymphoma, where detection assays for endonuclease activity have been used for screening and prognosis. Defects in nucleotide excision repair endonucleases, such as XPF and XPG, cause xeroderma pigmentosum, a condition with extreme UV sensitivity and cancer predisposition. These findings highlight the importance of endonuclease function in maintaining genomic stability and preventing oncogenesis.
Immunodeficiency and V(D)J recombination
Artemis is essential for V(D)J recombination, and mutations in ARTEMIS cause radiosensitive severe combined immunodeficiency (RS-SCID). DNA-PKcs regulates Artemis endonuclease activity, and disruption of this regulation impairs lymphocyte development. This demonstrates the critical role of DNA endonucleases in immune system function.
Neurodegeneration and genome instability
Defective DNA endonuclease activity can lead to accumulation of DNA damage, which is a hallmark of neurodegenerative disorders. Although direct evidence for specific endonucleases in neurodegeneration is limited in the provided citations, the general principle that unrepaired DNA breaks contribute to neuronal death is well established. Further research is needed to link specific endonucleases to neurodegenerative diseases.
From DNA endonuclease activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ARTEMIS endonuclease activity impair V(D)J recombination? | ARTEMIS knockout cell line |
| Can point mutations in the catalytic domain abolish DNA cleavage? | Point-mutation knock-in of ARTEMIS |
| How does DNA-PKcs regulate Artemis activity? | Knock-in of tagged DNA-PKcs |
| What is the effect of TnpB overexpression on genome editing efficiency? | TnpB overexpression in mammalian cells |
| Does LINE-1 ORF2p endonuclease activity drive retrotransposition? | ORF2p knockout or overexpression |
| Can T7 endonuclease I detect UV-induced lesions? | In vitro cleavage assays with UV-treated DNA |
How to Study the DNA endonuclease activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro cleavage assay | DNA endonuclease activity | Enzyme characterization |
| CRISPR knockout screen | Gene function in DNA repair | Identifying novel endonucleases |
| Cryo-EM | Protein-DNA complex structure | Mechanistic studies |
| X-ray crystallography | Atomic structure of catalytic domain | Active site analysis |
| Gel electrophoresis | DNA fragmentation pattern | Cleavage specificity |
| Fluorescence-based assay | Real-time DNA cleavage | High-throughput screening |
| Clinical activity assay | Endonuclease activity in patient samples | Prognosis in lymphoma |
In vitro DNA cleavage assays
In vitro cleavage assays using purified enzymes and defined DNA substrates are the gold standard for measuring DNA endonuclease activity. These assays can detect nicking, linearization, and specific cleavage patterns, and are used to screen for inhibitors or activators. For example, T7 endonuclease I cleavage of UV-damaged DNA was demonstrated using such assays.
CRISPR-based screening
CRISPR knockout libraries enable systematic interrogation of genes involved in DNA endonuclease activity. By knocking out candidate genes and measuring DNA repair or editing outcomes, researchers can identify novel factors. This approach is particularly powerful for uncovering regulators of endonuclease function.
Structural biology and biophysics
X-ray crystallography and cryo-electron microscopy provide atomic-level insights into DNA endonuclease mechanisms. Structures of TnpB and LINE-1 ORF2p have revealed key catalytic residues and guide RNA interactions. These methods complement biochemical assays to build a complete mechanistic picture.
Clinical detection assays
Detection assays for DNA endonuclease activity have been developed for clinical applications, such as screening and prognosis of malignant lymphoma. These assays measure enzyme activity in patient samples and can correlate with disease outcomes, highlighting the translational potential of endonuclease research.
How CRISPR Can Be Used to Study GO:0004520 DNA endonuclease activity
Knockout
CRISPR knockout of genes encoding DNA endonucleases, such as ARTEMIS or LINE-1 ORF2p, allows researchers to assess loss-of-function phenotypes in DNA repair, recombination, and retrotransposition. Knockout cell lines are valuable for validating drug targets and understanding disease mechanisms.
Point Mutation
Introducing point mutations in catalytic residues (e.g., DDE motif) of DNA endonucleases via CRISPR knock-in can abolish enzymatic activity while preserving protein interactions. This approach has been used to dissect the endonuclease versus exonuclease activities of ARTEMIS.
Knock-in
Knock-in of tagged versions of DNA endonucleases (e.g., GFP or FLAG) enables live-cell imaging and proteomic analysis. Tagged knock-in models are essential for studying localization, dynamics, and interacting partners of endonucleases such as Artemis and LINE-1 ORF2p.
Overexpression
Overexpression of DNA endonucleases like TnpB or LINE-1 ORF2p can enhance genome editing or retrotransposition, respectively. Overexpression models are used to study gain-of-function effects and to optimize biotechnological applications.
How EDITGENE Supports DNA endonuclease activity Research
Researchers studying DNA endonuclease activity-related genes often need to determine whether a candidate gene is causally involved in DNA cleavage, repair, or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research, from knockout and point mutation to knock-in, overexpression, library screening, and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for DNA endonuclease activity research.
Frequently Asked Questions About DNA endonuclease activity
What is DNA endonuclease activity?
DNA endonuclease activity (GO:0004520) is the catalysis of internal breaks in DNA by cleaving ester linkages within the deoxyribonucleic acid backbone.
What genes are involved in DNA endonuclease activity?
Key genes include TnpB, LINE-1 ORF2p, ARTEMIS, DNA-PKcs, T7 endonuclease I, XPF, XPG, and Cas9.
How is DNA endonuclease activity regulated?
It is regulated by protein-protein interactions (e.g., DNA-PKcs with Artemis), post-translational modifications, and guide RNA availability.
What diseases are associated with DNA endonuclease defects?
Defects are linked to malignant lymphoma, xeroderma pigmentosum, and radiosensitive SCID.
What methods are used to study DNA endonuclease activity?
Common methods include in vitro cleavage assays, CRISPR screens, cryo-EM, and clinical activity assays.
Can CRISPR be used to study DNA endonuclease activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of DNA endonucleases.
What is the role of Artemis in DNA endonuclease activity?
Artemis is a DNA endonuclease regulated by DNA-PKcs, involved in V(D)J recombination and DNA repair.
How does TnpB function as a DNA endonuclease?
TnpB is a programmable RNA-guided DNA endonuclease that uses a guide RNA to target and cleave DNA.
What is the clinical significance of DNA endonuclease activity?
Detection assays for DNA endonuclease activity have been used for screening and prognosis in malignant lymphoma.
What experimental models are available for DNA endonuclease research?
Models include knockout, point mutation, knock-in, and overexpression cell lines, as well as CRISPR library screens.
Conclusion
DNA endonuclease activity (GO:0004520) is a fundamental molecular function that creates internal breaks in DNA, enabling genome maintenance, recombination, and editing. Key enzymes such as TnpB, LINE-1 ORF2p, and Artemis have been structurally and biochemically characterized, revealing conserved catalytic mechanisms and diverse regulatory modes. Dysregulation of this activity is associated with cancer, immunodeficiency, and other diseases, underscoring its clinical relevance. CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, provide powerful tools to dissect the causal roles of DNA endonucleases in health and disease. EDITGENE offers comprehensive services to support these studies, from custom cell line generation to library screening and bioinformatics, accelerating discoveries in DNA endonuclease biology.
References
- 1. Karvelis T et al.. 2021. Transposon-associated TnpB is a programmable RNA-guided DNA endonuclease.. Nature 599(7886):692-696 PMID: 34619744
- 2. Jin W et al.. 2025. Mechanism of DNA targeting by human LINE-1.. Science 390(6769):eadu3433 PMID: 41066570
- 3. Gu J et al.. 2010. DNA-PKcs regulates a single-stranded DNA endonuclease activity of Artemis.. DNA Repair (Amst) 9(4):429-37 PMID: 20117966
- 4. Li S et al.. 2014. Evidence that the DNA endonuclease ARTEMIS also has intrinsic 5'-exonuclease activity.. J Biol Chem 289(11):7825-34 PMID: 24500713
- 5. Matsubara K et al.. 2024. Structure-specific DNA endonuclease T7 endonuclease I cleaves DNA containing UV-induced DNA lesions.. J Biochem 176(1):35-42 PMID: 38426948
- 6. Parrish DD et al.. 1992. Xeroderma pigmentosum endonuclease complexes show reduced activity on and affinity for psoralen cross-linked nucleosomal DNA.. Mutat Res 273(2):157-70 PMID: 1372099
- 7. Lu R et al.. 2018. Establishment of a detection assay for DNA endonuclease activity and its application in the screening and prognosis of malignant lymphoma.. BMC Biochem 19(1):6 PMID: 30064372
- 8. Sampson TR et al.. 2014. Exploiting CRISPR/Cas systems for biotechnology.. Bioessays 36(1):34-8 PMID: 24323919
